DE69606680D1 - 1-Alpha, 26-dihydroxy-D-homo-vitamin D3 - Google Patents

1-Alpha, 26-dihydroxy-D-homo-vitamin D3

Info

Publication number
DE69606680D1
DE69606680D1 DE69606680T DE69606680T DE69606680D1 DE 69606680 D1 DE69606680 D1 DE 69606680D1 DE 69606680 T DE69606680 T DE 69606680T DE 69606680 T DE69606680 T DE 69606680T DE 69606680 D1 DE69606680 D1 DE 69606680D1
Authority
DE
Germany
Prior art keywords
homo
dihydroxy
vitamin
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69606680T
Other languages
English (en)
Other versions
DE69606680T2 (de
Inventor
Fernand Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE69606680D1 publication Critical patent/DE69606680D1/de
Application granted granted Critical
Publication of DE69606680T2 publication Critical patent/DE69606680T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DE69606680T 1995-10-30 1996-10-18 1-Alpha, 26-dihydroxy-D-homo-vitamin D3 Expired - Fee Related DE69606680T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95117037 1995-10-30

Publications (2)

Publication Number Publication Date
DE69606680D1 true DE69606680D1 (de) 2000-03-23
DE69606680T2 DE69606680T2 (de) 2000-08-17

Family

ID=8219763

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69606680T Expired - Fee Related DE69606680T2 (de) 1995-10-30 1996-10-18 1-Alpha, 26-dihydroxy-D-homo-vitamin D3

Country Status (15)

Country Link
US (1) US5905074A (de)
EP (1) EP0771789B1 (de)
JP (1) JP3059108B2 (de)
CN (1) CN1157818A (de)
AR (1) AR004700A1 (de)
AT (1) ATE189812T1 (de)
BR (1) BR9605354A (de)
CA (1) CA2188634A1 (de)
DE (1) DE69606680T2 (de)
DK (1) DK0771789T3 (de)
ES (1) ES2144183T3 (de)
GR (1) GR3033254T3 (de)
MX (1) MX9605206A (de)
PT (1) PT771789E (de)
TR (1) TR199600849A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
US20020183288A1 (en) * 1995-04-03 2002-12-05 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) * 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US5965734A (en) * 1997-01-31 1999-10-12 Celgene Corporation Processes and intermediates for preparing 2-substituted piperidine stereoisomers
US20030129194A1 (en) * 1997-02-13 2003-07-10 Bone Care International, Inc. Targeted therapeutic delivery of vitamin D compounds
ES2206981T3 (es) * 1997-07-17 2004-05-16 F.Hoffmann-La Roche Ag Dihomo-seco-colestanos con dos enlaces insaturados en la cadena lateral.
US6087350A (en) * 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
US5919986A (en) * 1997-10-17 1999-07-06 Hoffmann-La Roche Inc. D-homo vitamin D3 derivatives
WO1999049870A1 (en) * 1998-03-27 1999-10-07 Oregon Health Sciences University Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders
WO2001016099A1 (fr) * 1999-08-27 2001-03-08 Chugai Seiyaku Kabushiki Kaisha DÉRIVÉS DE VITAMINE D AYANT DES SUBSTITUANTS À LA POSITION 2$g(a)
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
CA2414407A1 (en) * 2000-07-18 2002-01-24 Bone Care International, Inc. Stabilized 1.alpha.-hydroxy vitamin d
CN100391464C (zh) * 2001-12-03 2008-06-04 诺瓦西股份有限公司 含活性维生素d化合物的药物组合物
AU2002360015A1 (en) * 2001-12-26 2003-07-15 Chugai Seiyaku Kabushiki Kaisha 2-substituted vitamin d derivatives
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20050026877A1 (en) * 2002-12-03 2005-02-03 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
CA2514614C (en) * 2003-01-30 2011-09-13 Teijin Pharma Limited Vitamin d3 lactone derivatives
US20060189586A1 (en) * 2003-06-11 2006-08-24 Cleland Jeffrey L Pharmaceutical compositions comprising active vitamin D compounds
US20050020546A1 (en) * 2003-06-11 2005-01-27 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
EP1838667A2 (de) * 2004-11-22 2007-10-03 Wisconsin Alumni Research Foundation 2alpha-methyl-19-nor-1alpha-hydroxyhomoprägnacalciferol und anwendungen davon
JP4719284B2 (ja) 2008-10-10 2011-07-06 トヨタ自動車株式会社 表面検査装置
EA026334B1 (ru) * 2009-01-27 2017-03-31 БЕРГ ЭлЭлСи Применение соединения витамина d для предотвращения или снижения развития химиотерапевтически индуцированной нейтропении
CA2770683C (en) 2009-08-14 2018-09-04 Berg Biosystems, Llc Vitamin d3 and analogs thereof for treating alopecia
CN112156097A (zh) 2013-05-29 2021-01-01 博格有限责任公司 使用维生素d预防或减轻化疗诱发的脱发
CN105348163B (zh) * 2014-08-18 2017-06-16 武汉启瑞药业有限公司 维生素d类似物及其制备方法和医药用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697559A (en) * 1971-02-25 1972-10-10 Wisconsin Alumni Res Found 1,25-dihydroxycholecalciferol
US4410515A (en) * 1981-04-01 1983-10-18 Massachusetts General Hospital Vitamin D glycosides and a method of use
US4595776A (en) * 1983-03-21 1986-06-17 Hoffmann-La Roche Inc. Synthesis of 1α,25-dihydroxyergocalciferol
US4521410A (en) * 1984-05-03 1985-06-04 The General Hospital Corporation Vitamin D glycosyl orthoesters
AU666563B2 (en) * 1992-08-07 1996-02-15 Wisconsin Alumni Research Foundation Preparation of 19-nor-vitamin D compounds
AU699200B2 (en) * 1993-07-09 1998-11-26 Roger Bouillon Novel structural analogues of vitamin D
FR2709126B1 (fr) * 1993-08-18 1995-09-29 Adir Nouveaux dérivés de naphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
PT771789E (pt) 2000-05-31
JP3059108B2 (ja) 2000-07-04
BR9605354A (pt) 1998-07-28
DK0771789T3 (da) 2000-06-13
TR199600849A2 (tr) 1997-05-21
CA2188634A1 (en) 1997-05-01
DE69606680T2 (de) 2000-08-17
CN1157818A (zh) 1997-08-27
GR3033254T3 (en) 2000-09-29
US5905074A (en) 1999-05-18
ATE189812T1 (de) 2000-03-15
ES2144183T3 (es) 2000-06-01
MX9605206A (es) 1997-04-30
AR004700A1 (es) 1999-03-10
MX198725B (de) 2000-09-22
EP0771789A1 (de) 1997-05-07
EP0771789B1 (de) 2000-02-16
JPH09165369A (ja) 1997-06-24

Similar Documents

Publication Publication Date Title
ATE189812T1 (de) 1-alpha, 26-dihydroxy-d-homo-vitamin d3
DE69636353D1 (de) Datenübetragungsvorrichtung.
NL1004863A1 (nl) 5-Amino-4-ethylsulfinyl-1-arylpyrazolen.
TR199501724A2 (tr) Sizdirmazlik saglayici düzen.
FI950715A0 (fi) Ytmikromekanisk, symmetrisk tryckskillnadsgivare
NO960499L (no) Antineurodegenerativt virksomme 10-aminoalifatyldibenz[b,fÅoksepiner
NL1000095C2 (nl) Rolhor.
DK0874814T3 (da) 25-hydroxy-16-en-26,27-bishomo-cholecalciferoler
NL1000591C2 (nl) Weefsel.
ES1032571Y (es) Gafa,
ES1032948Y (es) Aplique.
IT1276501B1 (it) Via tranviaria.
ES1030500Y (es) Braga-compresa monouso.
IT239292Y1 (it) Volter.
ES1030124Y (es) Bloc-pizarra.
IT1282308B1 (it) Portaguinzagli.
ES1031849Y (es) Tapon-grifo.
ES1032636Y (es) Osario.
IT235624Y1 (it) Portatenda.
ES1032568Y (es) Protector-precinto.
IT240242Y1 (it) Pentola-colapasta-zuppiera.
ES1031132Y (es) Prensa-latas.
ES1030760Y (es) Tocado-postizo.
ES1033612Y (es) Octocarton.
ES1030262Y (es) Porta-objetos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee